Likewise, in gastric cancer cells (SGC7901 and AGS lines), BBR treatment suppressed cell proliferation, induced cell cycle arrest, and attenuated invasion via the down-regulation of C-myc, cyclin-D1, and MMP-3 expressions, respectively [78]. Here, MYC is linked to gastric cancer.